Indian Journal of Pharmaceutical Education and Research logo

Indian Journal of Pharmaceutical Education and Research · Archive

Volumes & Issues

Open a volume to see its issues, then pick an issue for its cover art and complete table of contents.

Keyboard: use Up/Down arrows to move between volumes, Home/End to jump to the first or last, and Enter to open or close a volume.

In this issue

21–25 of 25

Original Article(continued)

  1. Anjna Rani, Sunil Kumar, Roop K Khar

    pp. S326-S338 · DOI: 10.5530/ijper.56.2s.103 · 2022

    Background: Phytosome is a novel technique introduced by Indena that combines standardised herbal extract and phospholipid in preferably equal ratio to provide better absorption enhancing bioavailability. Purpose: The ob…

  2. Prem Prakash Singh, Srividya Gorantla, Ranendra N Saha, Gautam Singhvi

    pp. S339-S346 · DOI: 10.5530/ijper.56.2s.104 · 2022

    Background: The objective of this work is to develop and validate a reverse-phase HPLC method for determining Loteprednol Etabonate in self micro emulsifying drug delivery systems at nanogram level. Methods: A systematic…

  3. Murthannagari Vivek Reddy, Gonna Nandhi Krishnan Ganesh, Syed Suhaib Ahmed, Praharsh Kumar Mandadhi Rajendra, Eknath Babu

    pp. S347-S355 · DOI: 10.5530/ijper.56.2s.105 · 2022

    Introduction: Generic drug approval before patent expiration involves patent infringement petitions due to robust Life Cycle Management (LCM) strategies followed by Branded companies. They will extend the patent period o…

  4. Dilip Chandrasekhar, Mohammed Salim Karattuthodi, Linu Mohan Panakkal, Angel Mary William, Anjana A, Annmaria Benny, Aqila Karuppam, Beneta Sarah Sam, Shinu Cholamugath, Jaffer Chalil Parambil, Aneesh Puthiyedath Joy

    pp. S356-S364 · DOI: 10.5530/ijper.56.2s.106 · 2022

    Introduction: The meteoric spread of COVID-19 had facilitated the researchers to develop vaccines. One among the most recommended, Covishield requires further investigations for lighting up the society towards the immuni…

  5. Nitin Shirsath, Dipak Marathe, Priyanka Jaiswal, Laxmikant Zawar

    pp. S365-S373 · DOI: 10.5530/ijper.56.2s.107 · 2022

    Background: Azilsartan medoxomil (AZL) is an orally active nonpeptide angiotensin II receptor antagonist with less water solubility and oral bioavailability. Objectives: Increase the solubility and dissolving rate of AZL…